Freemont Management’s Abbott ABT Stock Holding History

Freemont Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-27,000	Closed	-$3.13M	–	110
2021 Q2	$3.13M	Buy	+27,000	New	+$3.15M	0.45%	66

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Freemont Management's ABT Position: Q2 2026 in Review

Freemont Management sold out of Abbott (ABT) in Q2 2026, closing a stake of 9,700 shares — an estimated $996K sold.

Freemont Management first reported a position in ABT in Q4 2020 and held it in 21 quarters. The position peaked at $11.4M in Q1 2021. 2,982 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Freemont Management reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
Freemont Management sold 9,700 Abbott shares in Q2 2026, an estimated $996K.
Freemont Management first reported a position in Abbott in Q4 2020 and held it in 21 quarters.
Freemont Management's Abbott position peaked at $11.4M in Q1 2021.
2,982 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Freemont Management's 13F filing for Q2 2026, filed 11 Aug 2026.